SIBN - Si-Bone - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8257041090
Surgical Implants, Bone Products, Medical Devices
SI-BONE, Inc. is a medical device company that specializes in developing innovative solutions to address musculoskeletal disorders affecting the sacropelvic anatomy, a complex region that includes the sacrum, pelvis, and surrounding joints.
The company's proprietary implant system is designed to be minimally invasive, reducing recovery time and scarring for patients. This system is used to treat a range of conditions, including sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma.
SI-BONE's product portfolio includes the iFuse-3D, a titanium implant that combines a triangular cross-section with a proprietary 3D-printed porous surface and fenestrated design. This implant is designed to promote bone growth and fusion. The company also offers iFuse-TORQ, a set of 3D-printed threaded implants specifically designed to treat pelvic trauma, and the iFuse Bedrock Granite implant, which provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.
SI-BONE's products are marketed primarily through a direct sales force, as well as through agents and resellers. This allows the company to reach a wide range of healthcare professionals and patients around the world.
Founded in 2008, SI-BONE, Inc. is headquartered in Santa Clara, California, and has established itself as a leader in the development of innovative solutions for musculoskeletal disorders. With a strong focus on research and development, the company is committed to improving patient outcomes and advancing the field of orthopedic medicine.
For more information, please visit SI-BONE's website at https://si-bone.com.
Drawdown (Underwater) Chart
SIBN Stock Overview
Market Cap in USD | 548m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Supplies |
TER | 0.00% |
IPO / Inception | 2018-10-17 |
SIBN Stock Ratings
Growth 5y | -38.5 |
Fundamental | -59.2 |
Dividend | |
Rel. Performance vs Sector | -5.25 |
Analysts | 4.56/5 |
Fair Price Momentum | 10.32 USD |
Fair Price DCF | - |
SIBN Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
SIBN Growth Ratios
Growth Correlation 3m | -59.4% |
Growth Correlation 12m | -74.6% |
Growth Correlation 5y | -34.1% |
CAGR 5y | -5.92% |
CAGR/Mean DD 5y | -0.16 |
Sharpe Ratio 12m | -0.50 |
Alpha vs SP500 12m | -84.12 |
Beta vs SP500 5y weekly | 1.46 |
ValueRay RSI | 19.26 |
Volatility GJR Garch 1y | 47.63% |
Price / SMA 50 | -15.2% |
Price / SMA 200 | -21.14% |
Current Volume | 794.1k |
Average Volume 20d | 369.2k |
External Links for SIBN Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 29, 2024, the stock is trading at USD 12.27 with a total of 794,101 shares traded.
Over the past week, the price has changed by -4.74%, over one month by -8.30%, over three months by -18.90% and over the past year by -27.87%.
According to ValueRays Forecast Model, SIBN Si-Bone will be worth about 11.6 in October 2025. The stock is currently trading at 12.27. This means that the stock has a potential downside of -5.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 23.3 | 90.1 |
Analysts Target Price | 28.4 | 131 |
ValueRay Target Price | 11.6 | -5.79 |